Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I recently had the incredible opportunity to participate in the Plasma Protein Therapeutics Association (PPTA) meetings, both at the Plasma Protein Forum and the Business Forum.
Engaging with fellow industry members during these discussions was enlightening and enriching.
Speaking on a panel at the Business Forum—a meeting dedicated solely to plasma industry members—was a particular highlight.
We delved into crucial topics like ethical decision-making, the importance of industry collaboration, and the need for a broader industry representation in PPTA, which are crucial for driving progress in our field.
I’m proud to represent Takeda and BioLife Plasma Services and contribute to conversations on how we can collectively shape the future, ensure ethical practices, and meet patient needs.
Advocacy, transparency, and education remain paramount as we work towards improving both understanding and perception of the plasma industry across the globe.
Grateful for the opportunity to engage and learn, I look forward to continuing these important efforts alongside my esteemed colleagues to work collectively and collaboratively to meet patient needs!”

Stay updated with Hemostasis Today.
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
-
Mar 14, 2026, 19:19Yunpeng Xue: Humbled and Honored to Receive the 2025 Eberhard F. Mammen Young Investigator Award
-
Mar 14, 2026, 19:13Abhilasha Singh: A Novel Mechanism of Cardiac Aging and Disruption of The Neurovascular Network
-
Mar 14, 2026, 19:08Saleh Owimer: The Critical Rules of Safe Blood Transfusion
-
Mar 14, 2026, 19:01Omar Adwan: Correcting Lipemic Samples in CBC Using the Plasma Replacement Method
-
Mar 14, 2026, 16:28Abdul Mannan: Advancing VWF Activity Testing Beyond VWF:RCo in Clinical Laboratories
-
Mar 14, 2026, 16:26Rida Fatima: When The Body’s Most Vital Production Unit Stops Working
-
Mar 14, 2026, 16:16Martin Haluzík: Metabolic Risk Factors and Therapeutic Opportunities in Cardiovascular Disease
-
Mar 14, 2026, 16:10Raffaella Colombatti: Proud to Have Authored the New Lancet Seminar on Sickle Cell Disease